Studies on the fibrinolytic enzyme system in obesity
Open Access
- 1 May 1966
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 19 (3) , 241-243
- https://doi.org/10.1136/jcp.19.3.241
Abstract
Plasma fibrinolytic activity, inhibitors of fibrinolysis, and fibrinogen were estimated in 34 subjects of varying ratio of observed to standard weight. The inverse relationship between fibrinolytic activity and the ratio of observed to standard weight was confirmed. No significant correlation was found between anti-plasmin or anti-urokinase and the ratio of observed to standard weight. It was therefore concluded that the decreased plasma fibrinolytic activity in obese subjects is due to decreased production of plasminogen activator rather than to excessive inhibition.This publication has 9 references indexed in Scilit:
- FIBRINOLYSIS IN OBESITYThe Lancet, 1964
- Abnormal Plasminogen-Plasmin System Activity (Fibrinolysis) in Patients with Hepatic Cirrhosis: Its Cause and Consequences*Journal of Clinical Investigation, 1964
- Blood Fibrinolytic Activity in Diabetes Mellitus and Its Bearing on Ischaemic Heart Disease and ObesityBMJ, 1963
- RELATIONSHIP BETWEEN BLOOD FIBRINOLYTIC ACTIVITY AND BODY FATNESSThe Lancet, 1963
- A New Weight-for Height Standard based on British Anthropometric DataJournal of Epidemiology and Community Health, 1962
- FIBRINOLYSIS, BLOOD CLOTTING, SERUM LIPIDS AND BODY BUILD IN NATIVES OF NEW GUINEA AND AUSTRALIANSAustralasian Annals of Medicine, 1961
- THE MECHANISM OF CLOT DISSOLUTION BY PLASMIN*Journal of Clinical Investigation, 1959
- STUDIES ON ENHANCED FIBRINOLYTIC ACTIVITY IN MAN*Journal of Clinical Investigation, 1959
- A NEW METHOD FOR THE DETERMINATION OF FIBRINOGEN IN SMALL SAMPLES OF PLASMA1951